Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02529072
Title Nivolumab With DC Vaccines for Recurrent Brain Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Gary Archer Ph.D.
Indications

malignant astrocytoma

high grade glioma

Therapies

Nivolumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.